A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 16, 2021

Primary Completion Date

November 30, 2022

Study Completion Date

November 1, 2023

Conditions
LeishmaniasisCutaneous LeishmaniasesInsect Bites
Interventions
OTHER

biting by Phlebotomus duboscqi infected with Leishmania major

The first six subjects will be exposed to biting by Phlebotomus duboscqi infected by Leishmania major and assess the 'take rate', that is the number of subjects developing parasitologically confirmed cutaneous leishmaniasis (PCCL) lesions. If 6/6 subjects develop PCCL lesions no further recruitment will take place; if only \< 6 subjects develop PCCL lesions, then an adaptive design will be followed.

Trial Locations (1)

Unknown

Translational Research Facility, Department of Biology, University of York, York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

Department for International Development, United Kingdom

OTHER_GOV

lead

University of York

OTHER

NCT04512742 - A Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies | Biotech Hunter | Biotech Hunter